RWJBarnabas Health - Newark Beth Israel Medical Center — Newark, New Jersey

RWJBarnabas Health - Newark Beth Israel Medical Center is a clinical research site located in Newark, New Jersey, United States 07112.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

RWJBarnabas Health - Newark Beth Israel Medical Center has participated in 9 clinical trials with 8 currently active.

Therapeutic areas: Cardiac Toxicity, Early-stage Breast Cancer, Anatomic Stage 0 Breast Cancer AJCC v8.

Sponsors: Rutgers, The State University of New Jersey, Mridula George, MD, Lyudmyla Berim.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for RWJBarnabas Health - Newark Beth Israel Medical Center?

RWJBarnabas Health - Newark Beth Israel Medical Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has RWJBarnabas Health - Newark Beth Israel Medical Center conducted?

RWJBarnabas Health - Newark Beth Israel Medical Center has 9 clinical trials on record, with 8 currently active. Their work covers Cardiac Toxicity, Early-stage Breast Cancer, Anatomic Stage 0 Breast Cancer AJCC v8.

Is RWJBarnabas Health - Newark Beth Israel Medical Center accredited by Crixeo Health?

Yes — RWJBarnabas Health - Newark Beth Israel Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about RWJBarnabas Health - Newark Beth Israel Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.